Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Medical Devices — Retail - Devices. Per the activity note to the FY2024 annual report, the company sells single-use medical supplies, medical instruments and devices, and provides service.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 5,021 | 3,601 | 3,644 | 7,881 | 6,419 | 6,636 | 4,421 | -2.1% | |
| Total COGS | 3,638 | 2,679 | 2,741 | 5,605 | 4,835 | 4,688 | 2,560 | -5.7% |
| Gross Profit | 1,383 | 922 | 903 | 2,275 | 1,584 | 1,947 | 1,861 | +5.1% |
| Gross Margin | 27.6% | 25.6% | 24.8% | 28.9% | 24.7% | 29.3% | 42.1% | |
| 845 | 522 | 679 | 758 | 742 | 1,624 | 969 | +2.3% | |
| EBITDA | 538 | 400 | 224 | 1,517 | 842 | 323 | 892 | +8.8% |
| EBITDA Margin | 10.7% | 11.1% | 6.2% | 19.3% | 13.1% | 4.9% | 20.2% | |
| Total D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT / Operating Income | 538 | 400 | 224 | 1,517 | 842 | 323 | 892 | +8.8% |
| Total Other Income | 0 | 3 | 29 | 110 | 401 | 34 | 20 | nmf |
| Profit Before Tax | 538 | 402 | 253 | 1,407 | 1,243 | 357 | 872 | +8.4% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 35 | 0 | |
| Net Profit / (Loss) | 805 | 402 | 253 | 1,407 | 1,243 | 322 | 872 | +1.3% |
| Net Margin | 16.0% | 11.2% | 6.9% | 17.9% | 19.4% | 4.9% | 19.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →